Jun Miyazaki
Impact in
Papers in
- Surgery 58
- Bladder and Urothelial Cancer Treatments 38
- Testicular diseases and treatments 14
- Urinary and Genital Oncology Studies 9
-
- Renal cell carcinoma treatment 8
- Prostate Cancer Diagnosis and Treatment 6
- Prostate Cancer Treatment and Research 5
- Co-authors
- Hiroyuki Nishiyama (58 shared papers)Koji Kawai (39 shared papers)Hideyuki Akaza (19 shared papers)Akira Joraku (17 shared papers)Ikuya Yano (8 shared papers)Takahiro Kojima (26 shared papers)Mizuki Onozawa (14 shared papers)Hideyoshi Harashima (5 shared papers)
- Journals
- Japanese Journal of Clinical Oncology (17 papers)International Journal of Urology (13 papers)International Journal of Clinical Oncology (5 papers)British Journal of Urology (3 papers)Prostate International (3 papers)
- Partner nations
- JapanUnited StatesMalaysia
In The Last Decade
Jun Miyazaki
103 papers receiving 1.8k citations
Jun Miyazaki's Hit Papers
Peers
Comparison fields: 5 of 99
- Surgery 947
- Oncology 369
- Urology 77
- Endocrinology 64
- Immunology 243
Countries citing papers authored by Jun Miyazaki
This map shows the geographic impact of Jun Miyazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Miyazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Miyazaki more than expected).
Fields of papers citing papers by Jun Miyazaki
This network shows the impact of papers produced by Jun Miyazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Miyazaki. The network helps show where Jun Miyazaki may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Miyazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 116 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2021 | 488 |
| 2 | 2017 | 183 | |
| 3 | 2012 | 139 | |
| 4 | 2014 | 74 | |
| 5 | 2002 | 42 | |
| 6 | The therapeutic effects of R8-liposome-BCG-CWS on BBN-induced rat urinary bladder carcinoma. | 2011 | 37 |
| 7 | 2015 | 37 | |
| 8 | 2016 | 32 | |
| 9 | 2002 | 29 | |
| 10 | 2006 | 28 | |
| 11 | 2015 | 26 | |
| 12 | 2008 | 25 | |
| 13 | 2013 | 25 | |
| 14 | 2018 | 25 | |
| 15 | 2014 | 24 | |
| 16 | 2013 | 22 | |
| 17 | 2014 | 22 | |
| 18 | 2019 | 21 | |
| 19 | 2021 | 20 | |
| 20 | 2014 | 20 |
About Jun Miyazaki
Jun Miyazaki is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Epidemiology, Urology and Endocrinology, having authored 116 papers that have together received 1.9k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (38 papers), Urinary Tract Infections Management (14 papers), Testicular diseases and treatments (14 papers), Urinary and Genital Oncology Studies (9 papers), Renal cell carcinoma treatment (8 papers), Prostate Cancer Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Surgery (947 citations), Oncology (369 citations), Urology (77 citations), Endocrinology (64 citations) and Immunology (243 citations). Jun Miyazaki has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Hiroyuki Nishiyama, Koji Kawai, Hideyuki Akaza, Akira Joraku, Ikuya Yano, Takahiro Kojima, Mizuki Onozawa, Hideyoshi Harashima, Tomokazu Kimura and Takehiro Oikawa. Their work appears in journals such as Japanese Journal of Clinical Oncology, International Journal of Urology, International Journal of Clinical Oncology, British Journal of Urology and Prostate International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.